Members of Congress are required to publicly disclose their stock trades within 45 days under the STOCK Act. These disclosures have attracted significant attention because legislators have access to non-public policy information that could affect stock prices.
Research has shown that some congressional portfolios have historically outperformed the market, raising questions about information asymmetry. Tracking these disclosures has become a popular strategy, though the 45-day delay limits real-time utility.
Information asymmetry is just the formal name for one side knowing more than the other. A senator who sits in a closed-door briefing on a coming regulation knows things the market doesn't. Whether that knowledge actually shows up in their trades — and whether you can profit by following along — turns out to be a messier question than the headlines suggest.
The Stop Trading on Congressional Knowledge Act — the STOCK Act — became law in April 2012, after a wave of media coverage suggested lawmakers were trading around information from their official duties. The law did two main things. First, it made explicit that members of Congress and their staff are covered by insider trading law and owe a duty not to trade on material non-public information learned through their positions. Second, it created the disclosure regime: any stock, bond, or fund transaction over 1,000 dollars must be reported in a Periodic Transaction Report within 30 to 45 days, and the reports must be posted publicly online.
Enforcement has been the soft spot. The penalty for a late filing starts at 200 dollars, and members have filed weeks or months late with little consequence. No member of Congress has ever been convicted of insider trading under the STOCK Act itself. Periodic reform proposals would ban individual stock ownership by lawmakers outright, but as of now, disclosure — not prohibition — is the rule.
The famous result comes from Alan Ziobrowski and coauthors, who studied Senate trades from 1993 to 1998 and found senators' stock purchases beat the market by a striking margin — roughly 85 basis points a month, an edge resembling corporate insiders'. A follow-up on House members found a smaller but still notable edge.
Here's the twist: later research on the post-STOCK Act era largely fails to find that outperformance. Several studies of disclosures from the 2010s onward found congressional trades performing about in line with the market, and sometimes worse. Popular tallies of headline-grabbing portfolios in a given year tend to reflect a few concentrated bets on stocks that were rising anyway.
How to square the two eras? Maybe sunlight worked and disclosure curbed the behavior. Maybe the early edge was overstated by small samples. Maybe the informed trades now hide in options, family accounts, or funds. The honest summary: evidence of an exploitable, ongoing edge in congressional trades as a group is weak — even though individual cases still raise eyebrows.
Suppose a lawmaker really did trade on privileged knowledge. Could you profit by copying the disclosure? Several layers of noise stand in the way.
The lag comes first. Forty-five days is an eternity; whatever the trade anticipated may have already happened by the time you can see it. Then there's imprecision — disclosures report dollar ranges, like 15,001 to 50,000 dollars, not exact amounts, so you can't gauge conviction. Many filings cover a spouse's trades or an adviser's discretionary account the member may never have touched. And no reason is given: a sale might mean dark knowledge, or a house down payment, or routine rebalancing.
The deepest problem is base rates. Hundreds of lawmakers file thousands of transactions a year, and the overwhelming majority are ordinary portfolio housekeeping. Even if a handful of trades carry real information, they're buried in a pile of noise with no label telling you which is which. Copy-trading the whole pile means mostly copying the housekeeping.
Congressional disclosures can still be interesting — as a research prompt, not a buy list.
The filters that make a filing worth a second look: committee relevance (a member of the armed services committee buying a defense contractor is more interesting than the same member buying an index fund), unusual size relative to that member's normal activity, options or concentrated single-stock bets rather than diversified funds, and clusters — several members buying the same name in the same window. Timing near major legislation or closed briefings adds weight; the trades around the January 2020 pandemic briefings drew scrutiny for exactly that pattern.
When a trade passes those filters, treat it as a question: what might this person plausibly know, and is there public evidence for the thesis? Then do the ordinary work of evaluating the stock. If the idea only makes sense because a politician bought it, that isn't research — it's borrowed conviction with a 45-day-old timestamp. Backtest any copy-trading rule with the disclosure delay honestly included, and expect the results to look far more ordinary than the headlines do.
Previous: Commitment of Traders (COT) · Next: Advanced Statistical Methods · Financial glossary
← Back to all investing concepts